The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.
Market view
penicillin g benzathin
1 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Penicillin-class Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- penicillin g· in shortage
- penicillin g benzathine· in shortage
- amoxicillin oral susp· 1 maker
- amoxicillin/clav pot· 1 maker
- amoxicillin/clav pot oral susp· 1 maker
- ampicillin injection· 1 maker
- buffered penicillin g potassium· 1 maker
- low mycosis nosode· 1 maker
- mycological immune stimulator· 1 maker
- mycosis nosode· 1 maker
- mycotoxin inhibitor· 1 maker
- omeprazole magnesium, amoxicillin and rifabutin· 1 maker
Common questions
- Is Penicillin g benzathin in shortage right now?
- Yes. FDA currently lists Penicillin g benzathin in shortage. This page is rebuilt every morning from FDA's shortage database.
- Who makes Penicillin g benzathin?
- 1 company has marketed Penicillin g benzathin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)Apr 26, 2023
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.